The Healthcare policy agenda encourages actions that drive investments in the healthcare sector in Brazil while helping to grow the economy, create jobs, and foster social stability and work-force productivity.
The Council recommends the agenda below:
- Further discussion of the economic impact caused by certain diseases in Brazil regarding the following:
- Public healthcare costs.
- Worker productivity decline.
- Preventable mortality and morbidity.
- Economic output.
- Promote cooperation between the U.S. and Brazilian governments with contributions from the private sector, through these actions:
- ANVISA and Food and Drug Administration (FDA) dialogue.
- Brazil-U.S. Commercial Dialogue.
- Memorandum of Understanding between the U.S. and Brazil on Health and Medical Sciences.
- Support for a technical dialogue between the FDA and ANVISA to discuss the FDA’s experience in dealing with sensitive products (e.g., biologicals, vaccines, perishable supplies, emergency supplies, samples) in the U.S. Encourage the government of Brazil to create a specific norm for express delivery of such sensitive products.
- Support initiatives that foster innovation and technology aimed at enhancing the following:
- Life expectancy.
- Quality of life.
- Diagnostic and treatment options.
- Efficiency and cost effectiveness of the healthcare system.
- Support efforts by ANVISA to address the bottlenecks through a combination of these measures:
- Implementation of increased risk assessment evaluation for low-risk (class I and II) medical devices.
- Modification of the ANVISA personnel rules allowing relocation and assignment of PAF (ports, airports, and borders) staff and resources to critically delayed ports.
- Implementation of an integrated and dynamic digital electronic system, eliminating all paper documents and allowing remote inspection of port documentation.
- Usage of increased emergency PAF funding and staffing to reduce backlog of inspection procedures.
- Recognize the importance of patent protection through both governments’ renewal and expansion of the scope of the Patent Prosecution Highway agreement, signed in 2015, to allow U.S. patent applications before Brazil’s National Institute of Industrial Property (INPI) in all technical fields for an unlimited time period.
Committee membership is voluntary and exclusive to our members, and each group is chaired by one or more members. Contact us if you are interested in getting involved.